Skip to main content
    M

    Moleculin Biotech Inc (MBRX)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $6.98
    -0.16 (-2.24%)

    Market Cap: $8.02M

    Last updated: Nov 17, 2026 at 4:10 PM ET

    Moleculin Biotech Inc (MBRX) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    Moleculin Biotech (MBRX) has a market cap of $8.02M and an enterprise value of $734.80K. Revenue fell 100.00% over the last 12 months from the 12 months before. It holds $7.29M more cash than debt, 90.84% of its market cap.

    Total Valuation

    Enterprise value is 90.84% below the market cap, as cash exceeds debt.

    Market Cap$8.02M
    Enterprise Value$734.80K
    Latest price (Nov 17, 2026)$6.98

    Key Dates

    The next earnings report is expected on Mar 16, 2027, covering the quarter ending Dec 31, 2026.

    Next Earnings DateMar 16, 2027 (expected)
    Last Earnings DateNov 13, 2026
    Fiscal Year EndDecember

    Share Statistics

    The share count fell 86.66% in the quarter ended Sep 30, 2026.

    Shares Outstanding757.86K
    Shares Change (QoQ)-86.66%

    Valuation Ratios

    P/B Ratio0.4x
    P/TBV Ratio1.6x

    Price Statistics

    The stock is down 96.78% over 52 weeks and trades 27.59% below its 50-day average.

    Beta (1Y)0.57
    52-Week Change-96.78%
    1-Month Change+31.70%
    3-Month Change-38.99%
    6-Month Change-85.15%
    5-Year Change-99.96%
    10-Year Change-99.99%
    Total Return (1Y)-96.78%
    Total Return (3Y CAGR)-88.35%
    Total Return (5Y CAGR)-78.82%
    Return vs SPY (1Y)-108.24%
    Max Drawdown (1Y)-97.58%
    Max Drawdown (3Y)-99.93%
    Sharpe Ratio (1Y)-2.08
    Correlation with SPY (1Y)0.05
    50-Day Average$9.64
    200-Day Average$35.55
    52-Week Range$3.23 to $227.05
    RSI (14 Days)37.6
    Average Volume (20 Days)36.24K

    The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Financial Position

    Current assets cover 1.37x current liabilities, and total debt is 0.00x shareholder equity.

    Current Ratio1.37x
    Quick Ratio1.37x
    Debt / Equity0.00x

    Returns and Efficiency

    Return on equity is -145.34% and return on assets is -101.55% over the last 12 months.

    Return on Equity (ROE)-145.34%
    Return on Assets (ROA)-101.55%
    ROA (5Y Average)-90.58%

    Scores

    MBRX has a Piotroski F-Score of 3 of 9, in the average band of 3 to 7.

    Piotroski F-Score3 of 9
    Piotroski StrengthAverage

    Income Statement

    Revenue was $0 over the last 12 months.

    Revenue$0
    Revenue Growth (YoY)-100.00%
    Gross Profit-$9.00K
    Operating Income-$29.58M
    Pretax Income-$21.12M
    Net Income-$21.06M
    EBITDA-$21.11M
    Reported EPS (TTM)-$9.70

    Trailing 12 months through Sep 30, 2026.

    Full financial statements

    Balance Sheet

    Shareholder equity funds 69.86% of the $20.74M in total assets.

    Cash and Equivalents$7.29M
    Total Debt$0
    Net Cash$7.29M
    Net Cash Per Share$9.62
    Working Capital$2.28M
    Shareholder Equity$14.49M
    Book Value Per Share$19.12
    Tangible Book Value$3.34M
    Tangible Book Per Share$4.41
    Total Assets$20.74M
    Total Liabilities$6.25M

    Balance sheet as of Sep 30, 2026.

    Full balance sheet

    Cash Flow

    Operating Cash Flow-$27.10M
    FCF Per Share-$26.59
    Depreciation and Amortization$33.00K

    Trailing 12 months through Sep 30, 2026.

    Full cash flow statement

    Dividends and Yields

    MBRX does not pay a dividend.

    Buyback Yield-463.30%
    Shareholder Yield-463.30%

    Stock Splits

    The last split was a 1-for-20 reverse split on Oct 20, 2026.

    Last Split DateOct 20, 2026
    Split TypeReverse split
    Split Ratio1:20

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    Frequently Asked Questions About MBRX

    What is MBRX's market cap?

    Moleculin Biotech has a market cap of $8.02M. Its enterprise value, which adds debt and subtracts cash, is $734.80K.

    How many shares of MBRX are outstanding?

    Moleculin Biotech has 757.86K shares outstanding.

    Does MBRX pay a dividend?

    No. Moleculin Biotech does not pay a dividend.

    How much debt does MBRX have?

    Moleculin Biotech has $0 of total debt and $7.29M of cash and equivalents, a net cash position of $7.29M.